Vaidya Sane Ayurved Laboratories Limited
MADHAVBAUG (NSE) · MADHAVBAUG (BSE 208578) · ISIN INE0JR301013 · Medical Equipment & Supplies · listed 2022
Not on any surveillance list
In Q2 FY25 (quarter to 30 September 2024, standalone), revenue was ₹41.02 cr and profit after tax ₹2.36 cr.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q2 FY25 standalone | ₹41.02 cr | ₹2.36 cr | 1.86 | 12 Nov 2024 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹64.64 cr | ₹2.59 cr | ₹97 cr |
| 30 Sep 2025 standalone | ₹62.92 cr | ₹0.63 cr | ₹75.62 cr |
| 31 Mar 2025 standalone | ₹59.7 cr | ₹1.46 cr | ₹73.83 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 66.34% | 0.00% | 0.00% | 33.66% |
Latest filings
- Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on September 04, 2026. 4 September 2026 · NSE
- Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on July 24, 2026. 24 July 2026 · NSE
- Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Transcript 20 May 2026 · NSE
- Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Audio recording of earnings conference 18 May 2026 · NSE
- Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Investor Presentation 17 May 2026 · NSE
Other companies in Medical Equipment & Supplies
- Poly Medicure Limited
- Tarsons Products Limited
- Vasa Denticity Limited
- Fabtech Technologies Limited
- Laxmi Dental Limited
- QMS Medical Allied Services Limited
- Nureca Limited
- Fischer Medical Ventures Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 30 September 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.